These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3000067)

  • 1. Presence of HBsAg and anti-HBs in patients with primary liver cancer or hepatic metastases.
    Nastac E; Stoian M; Iosipenco M; Iordache C
    Virologie; 1985; 36(3):181-6. PubMed ID: 3000067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orcein-positive hepatitis B surface antigen and liver carcinoma: their association in an Eastern US population.
    Keshgegian AA; Ochs RH
    Arch Pathol Lab Med; 1981 Apr; 105(4):190-3. PubMed ID: 6163416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody to hepatitis B core antigen in patients with hepatocellular carcinoma.
    Kubo Y; Okuda K; Hashimoto M; Nagasaki Y; Ebata H
    Gastroenterology; 1977 Jun; 72(6):1217-20. PubMed ID: 192626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue markers of hepatitis B virus infection in hepatocellular carcinoma and cirrhosis.
    Craxi A; Pasqua P; Giannuoli G; Di Stefano R; Simonetti RG; Pagliaro L
    Hepatogastroenterology; 1984 Apr; 31(2):55-9. PubMed ID: 6327478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HBeAg/anti-HBe system and development of primary hepatocellular carcinoma in patients with HBsAg-positive liver cirrhosis.
    Musca A; Cordova C; Barnaba V; Bonavita MS; Levrero M; Zaccari C; Balsano F
    Hepatogastroenterology; 1983 Feb; 30(1):3-5. PubMed ID: 6299916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma. A study of 50 autopsy cases with detection of hepatitis B surface antigen in fixed tissues.
    Perez-Barrios A; Colina-Ruizdelgado F; Gallego I; Martinez-Tello FJ
    Pathol Res Pract; 1983 Mar; 176(2-4):131-44. PubMed ID: 6190153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orcein staining for detection of hepatitis B surface antigen in cirrhosis and hepatic carcinoma in Thailand.
    Suwangool P
    J Med Assoc Thai; 1979 Aug; 62(8):422-8. PubMed ID: 90714
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma.
    Chen DS; Sung JL; Lai MY
    Hepatogastroenterology; 1981 Dec; 28(6):288-91. PubMed ID: 6284625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic hepatitis, liver cirrhosis, primary liver cancer and virus HB infection. Epidemiologic study in a sahelian hospital milieu. Apropos of 185 cases].
    Cénac A; Develoux M; Lamothe F; Soubiran G; Vetter JM; Trepo C
    Bull Soc Pathol Exot Filiales; 1985; 78(5 Pt 2):896-902. PubMed ID: 3015440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study of the humoral markers associated with hepatitis B virus in hepatocellular carcinoma patients and in subjects with chronic hepatopathy].
    de Franchis R; Primignani M; Vecchi M; Zannier PM; Colombo M; Colucci G; Antoniozzi F; Tommasini M
    Ann Sclavo; 1982; 24(1):37-48. PubMed ID: 6303232
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression of insulin-like growth factor II in chronic hepatitis B, liver cirrhosis, and hepatocellular carcinoma.
    Seo JH; Park BC
    Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():292-307. PubMed ID: 7661600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma.
    Szczepański W
    Pol J Pathol; 1997; 48(3):147-57. PubMed ID: 9401407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatocellular carcinoma (CHC) in patients chronically infected with HBV].
    Zielińska W; Kiszkis H; Dybicki J; Zbrzeźniak G; Zółtowska A; Jankowski Z; Sliwińska I
    Przegl Epidemiol; 1991; 45(4):279-85. PubMed ID: 1668701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case-control study of hepatitis B virus infection in chronic liver disease and hepatocellular carcinoma.
    de Franchis R; Primignani M; Vecchi M; Antoniozzi F; Colombo M; Colucci G; Tommasini M
    Ric Clin Lab; 1984; 14(1):81-8. PubMed ID: 6328629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B surface antigen in hepatocellular carcinoma.
    Tanaka K; Mori W
    Jpn J Cancer Res; 1985 Jul; 76(7):603-7. PubMed ID: 2993215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HBS Ag-positive hepatocellular cancer (pathomorphologic study)].
    Bardadin K; Kobushevska-Farina M
    Arkh Patol; 1979; 41(8):45-9. PubMed ID: 226040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus serological markers in Africans with liver cirrhosis and hepatocellular carcinoma.
    Coursaget P; Chiron JP; Barres JL; Barin F; Cottey P; Tortey E; Yvonnet B; Diop B; MBoup S; Diop-Mar I
    IARC Sci Publ; 1984; (63):181-98. PubMed ID: 6085625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The relation of hepatitis B virus to chronic hepatitis, cirrhosis and primary hepatocellar carcinoma--a study of 367 cases of liver biopsy with orcein staining].
    Tang YH
    Zhonghua Nei Ke Za Zhi; 1983 Jan; 22(1):17-20, 62-3. PubMed ID: 6188585
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan.
    Chien MC; Tong MJ; Lo KJ; Lee JK; Milich DR; Vyas GN; Murphy BL
    J Natl Cancer Inst; 1981 Mar; 66(3):475-9. PubMed ID: 6162990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of HBs antigen in livers revealed by orcein staining.
    Nakaso S; Sakurai M
    Hepatogastroenterology; 1982 Feb; 29(1):9-12. PubMed ID: 6178673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.